The Fidelity Health Care ETF is an exchange-traded fund designed to provide investors with exposure to a diverse range of companies within the healthcare sector. Its primary function is to track the performance of the health care sector index, encompassing industries such as pharmaceuticals, biotechnology, medical devices, and healthcare equipment. This ETF offers a broad representation of the healthcare industry, capturing firms engaged in the research, development, production, and marketing of healthcare goods and services. Significant due to its comprehensive reach across pivotal companies within the sector, the Fidelity Health Care ETF is crucial for those looking to balance portfolios with healthcare exposure. It reflects the market's confidence in the healthcare industry's growth potential and resilience, given the sector's essential nature and constant innovation. Healthcare is a critical field, often driven by demographic shifts, technological advancements, and a continuous focus on public health and wellness, making this ETF a significant player in investment portfolios seeking exposure to these dynamic and important areas of the economy.
United States
FHLC delivered 24% returns over one year with a 0.08% expense ratio, while IXJ offers global diversification but trails on performance and costs more to own.
One fund offers broad sector exposure at 0.08% cost; the other concentrates on 30 biotech stocks with higher volatility but stronger recent returns.
FHLC captures the whole healthcare opportunity at rock-bottom cost. XPH narrows the bet to pharmaceuticals and charges significantly more for it.
Invesco's biotech fund surged 56.4% in one year, while Fidelity's broader healthcare portfolio offers lower costs and steadier returns.
VanEck's concentrated 26-stock portfolio has outpaced Fidelity's broader 334-holding fund over five years, but at a steeper cost and higher volatility.
Fidelity's lower 0.08% fee and broader 338-stock portfolio contrast sharply with iShares' concentrated pharma play, which delivered 60% returns in one year.
Investors talking about FHLC also mention
What share of all ETF conversation is about FHLC?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0.01% +0.01 | 0.01% 0 | 0.01% 0 | 0.01% +0.01 |
Of the messages about FHLC that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | 100% | 100% 0 | 100% 0 | 80.98% +14.31 | ||
| Bearish | 0% | 0% 0 | 0% 0 | 19.02% -14.31 |
Of the messages about FHLC that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Macro | — | — | — | 50% | ||
| Technical Analysis | — | — | — | 50% |
Of the messages about FHLC, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | 100% | 98.65% | 90.06% | 1.73% | ||
| Newcomers | 0% | 1.35% | 9.94% | 98.27% |